Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome with plasm exchange plus rituximab and tacrolimus: one case report

Pu Jin-yun; Chen Ya-xian; He Yong-hua; Zhang Yu

doi:10.3969/j.issn.1671-2390.2021.10.014

Pu Jin-yun, Chen Ya-xian, He Yong-hua, Zhang Yu. Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome with plasm exchange plus rituximab and tacrolimus: one case report[J]. Journal of Clinical Nephrology, 2021, 21(10): 874-877. DOI: 10.3969/j.issn.1671-2390.2021.10.014

Citation:

Pu Jin-yun, Chen Ya-xian, He Yong-hua, Zhang Yu. Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome with plasm exchange plus rituximab and tacrolimus: one case report[J]. Journal of Clinical Nephrology, 2021, 21(10): 874-877. DOI: 10.3969/j.issn.1671-2390.2021.10.014

Citation:

Pu Jin-yun, Chen Ya-xian, He Yong-hua, Zhang Yu. Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome with plasm exchange plus rituximab and tacrolimus: one case report[J]. Journal of Clinical Nephrology, 2021, 21(10): 874-877. DOI: 10.3969/j.issn.1671-2390.2021.10.014

Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome with plasm exchange plus rituximab and tacrolimus: one case report

Graphical Abstract

Abstract

FullText(HTML)

References (15)

Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome with plasm exchange plus rituximab and tacrolimus: one case report

Catalog

Export File

Citation

Format

Content